Moderna Inc. buy UBS Group AG
Start price
07.05.24
/
50%
€110.94
Target price
07.05.25
€140.14
Performance (%)
-46.92%
Price
27.09.24
€58.89
Summary
This prediction is currently active. Massive losses of -46.92% have been the result for the BUY prediction by UBS_Group_AG. This prediction currently runs until 07.05.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Moderna Inc. | 0.085% | 0.085% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at UBS Group AG from $143.00 to $151.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat